Estimation of causal equivalence effects in clinical bioequivalence/biosimilar studies in the presence of intercurrent events: Noncompliance and missing data
between a generic and an innovator product is usually based on the observed per-protocol (PP) population. However, missing data and non-compliance are post-randomization intercurrent events ... robustness of the current…

